Green Shoots: Pharma Investments In Early Innovation Support Biotech Growth

 
• By Mandy Jackson

Big pharma investments in early innovation are paying off in ways that still are hard to measure in any concrete way, but green shoots are sprouting through the pavement as startups supported by multimillion-dollar initiatives evolve from concept to reality.

Boehringer Ingelheim GMBH Corporate Senior Vice President and Head of Discovery Research Clive Wood • Source: Boehringer Ingelheim GmbH (Michael Kettel Michael Kettel Fotografie)

More from Business

More from Scrip